Octapharma USA sponsored the National Hemophilia Foundation’s (NHF) 71st Bleeding Disorders Conference and introduced two new clinical trials focused on von Willebrand Disease (VWD). The clinical trials were featured in poster...
The National Organization for Rare Disorders® (NORD), the leading independent nonprofit organization representing the 25-30 million Americans living with rare diseases, is celebrating the 30th anniversary of its Rare Disease Research Grant Program by announcing the...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
